HAXBY GROUP HULL — All Prescriptions & Medications — Page 4
Practice Code: Y02747 | HULL, HU7 3JQ
Showing results 151-200 of 662
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Orlistat | 354 | 29.8K | £7.2K | +329.5% ▲ |
| Nicorandil | 348 | 16.3K | £2.4K | +141.7% ▲ |
| Dexamethasone | 335 | 1,695 | £1.1K | +94.8% ▲ |
| Lymecycline | 332 | 10.5K | £1.2K | +176.0% ▲ |
| Methotrexate | 331 | 8,516 | £577 | +1.7% vs avg |
| Powder extensively hydrolysed formula (0913101) | 326 | 1.1M | £32.2K | +352.5% ▲ |
| Diazepam | 324 | 10.2K | £399 | -35.0% ▼ |
| Chlorphenamine maleate | 318 | 38.9K | £1.2K | +188.1% ▲ |
| Esomeprazole | 314 | 11.6K | £929 | -22.4% ▼ |
| Calcipotriol | 314 | 23.9K | £13.5K | +84.4% ▲ |
| Paroxetine hydrochloride | 307 | 8,175 | £680 | +64.5% ▲ |
| Insulin glargine | 306 | 1,093 | £11.1K | +7.8% ▲ |
| Tadalafil | 302 | 4,416 | £2.0K | +77.6% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 294 | 296 | £13.1K | +75.8% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 294 | 21.6K | £1.7K | +30.1% ▲ |
| Ranolazine | 291 | 12.2K | £2.3K | +71.2% ▲ |
| Hydroxychloroquine sulfate | 291 | 12.2K | £568 | +50.3% ▲ |
| Beclometasone dipropionate | 291 | 294 | £915 | +35.3% ▲ |
| Perindopril erbumine | 285 | 8,322 | £720 | -46.3% ▼ |
| Olanzapine | 280 | 9,590 | £902 | -24.4% ▼ |
| Mesalazine (Systemic) | 278 | 27.2K | £13.0K | +16.1% ▲ |
| Fusidic acid | 278 | 4,875 | £627 | +117.7% ▲ |
| Docusate sodium | 277 | 28.5K | £2.4K | -25.3% ▼ |
| Oxybutynin | 274 | 16.8K | £1.7K | +43.8% ▲ |
| Rivaroxaban | 268 | 6,778 | £5.2K | -56.2% ▼ |
| Diltiazem hydrochloride | 267 | 10.5K | £1.8K | -13.1% ▼ |
| Digoxin | 265 | 7,329 | £548 | -30.0% ▼ |
| Prochlorperazine maleate | 257 | 9,157 | £539 | +27.1% ▲ |
| Escitalopram | 256 | 7,533 | £480 | -10.1% ▼ |
| Estriol | 256 | 5,521 | £3.7K | +20.3% ▲ |
| Clotrimazole | 254 | 1,871 | £1.8K | +130.2% ▲ |
| Aciclovir | 253 | 9,634 | £514 | +70.1% ▲ |
| Dihydrocodeine tartrate | 252 | 19.2K | £2.0K | +29.0% ▲ |
| 250 | 35.1K | £904 | -9.6% ▼ | |
| 248 | 2,424 | £880 | -0.6% vs avg | |
| 246 | 2,875 | £869 | +17.7% ▲ | |
| Aripiprazole | 245 | 5,527 | £736 | -3.7% ▼ |
| Metoclopramide hydrochloride | 242 | 23.7K | £1.6K | +192.1% ▲ |
| Estradiol | 239 | 5,456 | £2.6K | -11.4% ▼ |
| Methylphenidate hydrochloride | 237 | 14.6K | £7.3K | -8.2% ▼ |
| Emollient bath and shower preparations | 234 | 110.0K | £1.6K | +272.5% ▲ |
| Indacaterol/glycopyrronium | 231 | 6,870 | £7.1K | +411.6% ▲ |
| Nifedipine | 230 | 14.4K | £4.0K | +22.7% ▲ |
| Cyclizine hydrochloride | 230 | 13.0K | £473 | +42.6% ▲ |
| Sulfasalazine | 229 | 29.1K | £4.4K | +75.9% ▲ |
| Insulin Lispro | 227 | 1,454 | £11.3K | +196.7% ▲ |
| Tirzepatide | 227 | 253 | £24.8K | +16.9% ▲ |
| Ketone blood testing reagents | 225 | 2,760 | £2.5K | +232.5% ▲ |
| Nystatin | 222 | 7,890 | £452 | +120.2% ▲ |
| Quinine sulfate | 222 | 4,686 | £766 | -23.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.